Lab Member Updates

Yetunde presents at the Innovators of Tomorrow Symposium

Yetunde was invited to present her research project at the Innovators of Tomorrow Symposium that was held at the Moffitt Comprehensive Cancer Center in Tampa, FL. This is a competitive, two-day career and networking event for trainees interested in a postdoctoral fellowship in cancer research.

Yetunde presented at The Annual Retreat of the Program in Translational and Cellular Oncology

Yetunde was selected to presented her work titled Mechanistic insights for the transcriptional regulation of IL-1b by the AR in prostate cancer at The Annual Retreat of the Program in Translational and Cellular Oncology at the Sidney Kimmel Comprehensive Cancer Center in Philadelphia

Jaden Drumm wins Pennoni Honor College grant

Jaden Drumm was awarded an undergraduate research mini grant by the Pennoni Honor College of Drexel University

Alessandro Fatatis is appointed Associate Director for Basic Research at the Sidney Kimmel cancer Center of Thomas Jefferson University.

Alessandro Fatatis is appointed Associate Director for Basic Research at the Sidney Kimmel cancer Center of Thomas Jefferson University.

Our lab was awarded a five-year R01 grant titled: Interleukin-1beta and AR-negative tumor cells in metastatic castrate-resistant prostate cancer.

August 18, 2022 This new grant will support studies employing animal models of metastasis, human cell lines, PDX-derived cells and human tissue samples to ascertain the functional role of IL-1𝛽 in skeletal colonization of prostate cancer cells, discriminating between direct autocrine-paracrine effects on cancer cells and targeting cells of the tumor-associated bone stroma. Furthermore, we […]

Our lab receives a second research grant from the Philadelphia Prostate Cancer Biome Project. April 20, 2022

This new grant will support collaborative studies between our group and the lab of Dr. David Sykes at the Harvard Stem Cell Institute. The research project titled Direct and combinatorial anti-tumor effects of CX3CR1 antagonists in prostate cancer, will be funded for one year.

Anna Zhang passes her Qualifying Exam and is now a PhD candidate

Anna Zhang passes her Qualifying Exam and is now a PhD candidate.

Anthony DiNatale starts as a post-doctoral fellow at Janssen in the Exploratory Biology/Therapeutic Discovery Group

Anthony DiNatale starts as a post-doctoral fellow at Janssen in
the Exploratory Biology/Therapeutic Discovery Group.